col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


60 Ergebisse       Seite 1

 [1] 
BMJ: European Journal of Hospital Pharmacy
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Dez―23 Retrospective service evaluation of clinical pharmacist involvement in a critical care COVID-19 rehabilitation clinic David Sapsford, Helen Dufton, Monica Trivedi, Joanne McPeake, Andrew Conway Morris
2 [GO] 2024―Jun―13 Retrospective study of patient characteristics and treatment for mucormycosis in post COVID-19 population in a tertiary care hospital Jada Naga Lakshmi, Jada Bala Sai Kalyan, Tanniru Govardhana Priya, Tummala Sushma, Gaddam Rukmini, R V L S Mounica, Tinnaluri Vishnu Vardhan
3 [GO] 2024―Mai―15 An essential component of antimicrobial stewardship during the COVID-19 pandemic in the intensive care unit: de-escalation Aysel Pehlivanli, Cigdem Ozgun, Firdevs Gonca Sasal-Solmaz, Didem Yuksel, Bilgen Basgut, Arif Tanju Ozcelikay, Mustafa Necmettin Unal
4 [GO] 2024―Feb―06 Analysis of the use of antibiotics by AWaRe categories during the COVID-19 pandemic in hospitals across Scotland: a national population-based study Euan Proud, Tanja Mueller, Karen Gronkowski, Amanj Kurdi, Niketa Platt, Aidan Morrison, et al. (+2)
5 [GO] 2023―Okt―24 Clinical pharmacy as a guarantee of safety in times of crisis: evolution and relevance of the continued presence of clinical pharmacists in frontline medical units during the first wave of COVID-19 Arnaud Tanty, Elisa Vitale, Dorothée Lombardo-Duron, Armance Grevy, Prudence Gibert, Claire Chapuis, et al. (+4)
6 [GO] 2023―Aug―17 COVID-19 vaccine triggered autoimmune hepatitis: case report Merrin Mathew, Sheba Baby John, Juny Sebastian, Mandyam Dhati Ravi
7 [GO] 2023―Jun―20 Real-world effectiveness and factors associated with increased mortality in non-critically ill patients with COVID-19 pneumonia receiving remdesivir Lucía Quesada Muñoz, Jorge Fernández-Fradejas, Hilario Martinez-Barros, Marina Sánchez Cuervo, Miriam Martín Rufo, Maria del Rosario Pintor Recuenco, et al. (+3)
8 [GO] 2023―Feb―03 Correspondence on ‘Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series’ Xiaohua Xiao Zhou, Hong Jian Ji
9 [GO] 2022―Dez―19 Management of nirmatrelvir/ritonavir and tacrolimus interaction in kidney transplant recipients infected by COVID-19: a three-case series Carlos Guzmán Cordero, Maria Saez-Torres de Vicente
10 [GO] 2022―Okt―27 Use of chronic medications and risk of severe death due to COVID-19 in hospitalised patients María Larrosa-García, Sonia Garcia-Garcia, Javier Louro, Adrián Sánchez-Montalvá, Julia Sampol Sirvent, Salvador Augustín Recio, et al. (+4)
11 [GO] 2022―Okt―07 COVID-19 vaccine triggered autoimmune hepatitis: case report Merrin Mathew, Sheba Baby John, Juny Sebastian, Mandyam Dhati Ravi
12 [GO] 2022―Okt―06 Monoclonal antibodies for the early treatment of paediatric COVID-19 patients: a tangible contribution from hospital pharmacists in the lack of evidence Sabrina Trivellato, Daniele Mengato, Daniele Donà, Marica De Pieri, Francesca Venturini
13 [GO] 2022―Sep―23 Assessment of the effectiveness of tocilizumab on mortality and progression to mechanical ventilation or intensive care in patients with COVID-19 admitted to a tertiary hospital Andrea Pinilla Rello, Arantxa Magallón Martínez, Cristina Vicente Iturbe, Angel Escolano-Pueyo, Elena Herranz Bayo, Irene Aguilo Lafarga
14 [GO] 2022―Aug―23 EAHP’s COVID-19 Report showcases the contributions of hospital pharmacists and shares recommendations Gonzalo Marzal Lopez
15 [GO] 2022―Apr―15 A qualitative evaluation of weekly reflective practice sessions for the intensive care unit pharmacy team during the COVID-19 pandemic Naima Fowlis, Nina Barnett, Sara Banks, Barry Jubraj
16 [GO] 2022―Mrz―30 Analysis of clinical enquiries received by five COVID-19 vaccination centres in the UK Sukhpreet Bassi, Rubena Begum, Raliat Onatade, Catherine Olie
17 [GO] 2022―Jan―06 Tocilizumab in COVID-19 management: addressing time of starting treatment Sajad Khiali, Taher Entezari-Maleki
18 [GO] 2021―Okt―18 Medicine shortages in the hospital setting: analysis of the trend in five Italian centres during the three waves of the SARS-CoV-2 pandemic Ludovica Mazzoleni, Andrea Zovi, Cecilia Borsino, Cinzia D'Angelo
19 [GO] 2021―Okt―14 Effectiveness of antithrombotic prophylaxis in hospitalised patients with SARS-CoV-2 infection Helena Quiros Ambel, Paloma Crespo-Robledo, Karmele Arribalzaga Juaristi, Isabel Plo-Seco, Jose Javier Martínez Simón, Elia Pérez Fernández, Monserrat Perez Encinas
20 [GO] 2021―Sep―08 Lessons learnt from the COVID-19 pandemic: results of EAHP survey on the future crisis preparedness of hospital pharmacies Daniele Leonardi Vinci, Piera Polidori, Nenad Miljković, Aida Batista, Steffen Amann, Despina Makridaki, Stephanie Kohl
21 [GO] 2021―Aug―23 Preparation of COVID-19 vaccines in hospital pharmacies: a half-year report from Slovakia Boris Dudík, Ľubica Slimáková, Hajnalka Komjáthy, Melisa Švecová, Andrea Bundzelová, Bianka Oboňová, et al. (+2)
22 [GO] 2021―Aug―16 Risk factors for nosocomial bloodstream infections in COVID-19 affected patients: protocol for a case-control study Carla Codina-Jiménez, Sergio Marin, Marlene Álvarez, Maria Dolores Quesada, Beatriz Rodríguez-Ponga, Ester Valls, Carles Quiñones
23 [GO] 2021―Jul―28 Baricitinib against severe COVID-19: effectiveness and safety in hospitalised pretreated patients Rubén Iglesias Gómez, Raúl Méndez, Tomás Palanques-Pastor, Octavio Ballesta-López, Conxa Borrás Almenar, Juan Eduardo Megías Vericat, et al. (+5)
24 [GO] 2021―Jul―16 The dynamics in applied COVID-19 pharmacotherapy and the influence of national guidance in The Netherlands: a quantitative and qualitative study Elien B Uitvlugt, Danny Y F Soeng, Paul van der Linden, Ewoudt M W van de Garde
25 [GO] 2021―Jun―03 Benefit versus toxicity risk of digoxin in patients with COVID-19 Burcu Kelleci Cakir, Aygin Bayraktar-Ekincioglu, Kutay Demirkan
26 [GO] 2021―Mai―19 Treatment of high-risk bleeding with susoctocog alfa in a patient with acquired haemophilia A and a nosocomial severe acute respiratory syndrome coronavirus 2 infection Carla Fernández-Oliveira, Sandra Rotea-Salvo, Marta Fernández-Docampo, Sara González-Piñeiro, Isabel Martín-Herranz
27 [GO] 2021―Mai―14 Crushing lopinavir/ritonavir tablets does not result in lower exposure to lopinavir/ritonavir in adult patients with COVID-19 Shaghayegh Mohsenian Naghani, Mark MPM Jansen, Tessa Jaspers, Diane Bastiaans, David Burger
28 [GO] 2021―Mai―14 SARS-CoV-2: an opportunity for hospital pharmacy Raquel Claramunt García, Carmen Lucía Muñoz-Cid, Andrés Sánchez Ruiz
29 [GO] 2021―Apr―23 The European coalition for vaccination calls on healthcare professionals to get vaccinated against COVID-19 Stephanie Kohl
30 [GO] 2021―Apr―14 Hospital pharmacy response to COVID-19 at two UK teaching hospitals: a departmental review of actions implemented to inform future strategy Jeff Aston, Inderjit Singh, Caroline Cheng, Aisling Considine
31 [GO] 2021―Apr―13 COVID-19 impact on skills and professional perceptions of the hospital pharmacist during the first outbreak wave Vera Damuzzo, Riccardo Bertin, Daniele Mengato, Marco Chiumente, Melania Rivano, Angelo Claudio Palozzo
32 [GO] 2021―Apr―13 Hand hygiene for healthcare workers: did we need COVID-19 to raise awareness of proper disinfection practice? Daniele Mengato, Lorenzo Di Spazio
33 [GO] 2021―Apr―08 Electronic monitoring of potential adverse drug events related to lopinavir/ritonavir and hydroxychloroquine during the first wave of COVID-19 Christian Skalafouris, Caroline Samer, Jerome Stirnemann, Olivier Grosgurin, François Eggimann, Damien Grauser, et al. (+3)
34 [GO] 2021―Mrz―31 Managing the risk of shortages and medication errors with curares during the COVID-19 pandemic: a hospital pharmacy experience Xavier Bohand, Dominique Jordan, Frederique Dubois
35 [GO] 2021―Mrz―11 Analysis of clinical pharmacist interventions in the COVID-19 units of a French university hospital Maxime Perez, Morgane Masse, Anne Deldicque, Jean Baptiste Beuscart, Pascal De Groote, Jacques Desbordes, et al. (+7)
36 [GO] 2021―Feb―24 Does timing matter on tocilizumab administration? Clinical, analytical and radiological outcomes in COVID-19 Raquel Moreno Diaz, Miguel Angel Amor García, Francisco Javier Teigell Muñoz, Leonardo Ernesto Saldaña Perez, María Mateos Gonzalez, Jose Antonio Melero Bermejo, et al. (+5)
37 [GO] 2021―Feb―22 The European COVID-19 drugs calculation tool: an aid for the estimation of the drugs needed during the SARS-CoV 2 pandemic Daniele Leonardi Vinci, Adriano Meccio, Alessio Provenzani, Maria Ernestina Faggiano, Nenad Miljković, Despina Makridaki, et al. (+2)
38 [GO] 2021―Feb―19 EAHP opinion on COVID-19 vaccine programmes and their implementation Stephanie Kohl
39 [GO] 2021―Feb―19 Information on COVID-19 vaccines and vaccinations Stephanie Kohl
40 [GO] 2021―Feb―08 SARS-COV-2 pandemic: establishing three risk levels for 19 Italian regions and two autonomous provinces Andrea Messori, Manuela Angileri, Marco Chiumente, Laura Agnoletto, Paolo Baldo, Laura Bartoli, et al. (+8)
41 [GO] 2021―Feb―05 Haematology patients infected with SARS-CoV-2, pretreated with eculizumab or siltuximab, develop oligosymptomatic disease Sabina Iluta, Sergiu Pasca, Delia Dima, Gabriela Mester, Laura Urian, Anca Bojan, et al. (+4)
42 [GO] 2021―Jan―27 Web searches for anxiolytic drugs during the COVID-19 outbreak in the USA Giuseppe Lippi, Brandon M Henry, Fabian Sanchis-Gomar
43 [GO] 2021―Jan―27 Is sitagliptin effective for the treatment of COVID-19? Hasan Memiş, Ahmet Çakır, Mefküre DURMUŞ, Selim GÖK, Ömer Faruk Bahçeciȯğlu
44 [GO] 2021―Jan―15 A prospective, observational study to evaluate adverse drug reactions in patients with COVID-19 treated with remdesivir or hydroxychloroquine: a preliminary report Fátima Falcão, Erica Viegas, Ines Carmo, Joana Soares, Margarida Falcao, Mariana Solano, et al. (+14)
45 [GO] 2020―Dez―22 Some reflections on the current COVID-19 pandemic Philip Wiffen
46 [GO] 2020―Dez―22 Epinephrine use in COVID-19: friend or foe? Pan Luo, Dong Liu, Juan Li
47 [GO] 2020―Dez―05 Investigating the challenges and opportunities for medicines management in an NHS field hospital during the COVID-19 pandemic Jennifer de Val, Gurjit Sohal, Asif Sarwar, Haseeb Ahmed, Inderjit Singh, Jamie J Coleman
48 [GO] 2020―Nov―25 Prescribing practices of lopinavir/ritonavir, hydroxychloroquine and azithromycin during the COVID-19 epidemic crisis and pharmaceutical interventions in a French teaching hospital Benedicte Gourieux, Fanny Reisz, Anne Sophie Belmas, François Danion, Marion Fourtage, Thierry Nai, et al. (+5)
49 [GO] 2020―Nov―20 Prescription profile in patients with SARS-CoV-2 infection hospitalised in Aragon, Spain Adriana Alvarez, Laura Cabia, Cristina Trigo, Ana Cristina Bandrés, María Bestué
50 [GO] 2020―Okt―28 Implementation of a novel home delivery service during pandemic Ana Peláez Bejarano, Pilar Villar Santos, Maria de las Aguas Robustillo-Cortés, Ernesto Sánchez Gómez, Maria Dolores Santos Rubio
51 [GO] 2020―Sep―10 Observational study on off-label use of tocilizumab in patients with severe COVID-19 Laetitia Albertini, Mickael Soletchnik, Anais Razurel, Johana Cohen, Frédéric Bidegain, Francis Fauvelle, et al. (+4)
52 [GO] 2020―Jul―31 Consistency of recommendations from clinical practice guidelines for the management of critically ill COVID-19 patients Chia Siang Kow, Toby Capstick, Syed Tabish Razi Zaidi, Syed Shahzad Hasan
53 [GO] 2020―Jul―13 Informing critical care drug requirements in response to the COVID-19 pandemic Anita Hogg, Rachel Huey, Michael G Scott, Andrew Ferguson
54 [GO] 2020―Jul―03 Do psychotropic drugs used during COVID-19 therapy have an effect on the treatment process? Nadir Yalçın, Sertaç Ak, Kutay Demirkan
55 [GO] 2020―Jun―10 Fighting on two fronts: drug-drug interactions in people living with HIV infected with SARS-CoV-2 Melda Bahap, Emre Kara, Gulay Sain Guven
56 [GO] 2020―Jun―04 Involvement of interleukin 6 in SARS-CoV-2 infection: siltuximab as a therapeutic option against COVID-19 Tomás Palanques-Pastor, Eduardo López-Briz, José Luis Poveda Andrés
57 [GO] 2020―Mai―26 Investigation on cognition of covid-19 and safety during the pandemic among hospital pharmacy staff Yan He, Wei Li, Dong Liu
58 [GO] 2020―Apr―23 EAHP launches COVID-19 resource centre for hospital pharmacists Stephanie Kohl
59 [GO] 2020―Mrz―19 The healthcare and pharmaceutical vulnerability emerging from the new Coronavirus outbreak Daniele Leonardi, Carlo Polidori, Piera Polidori
60 [GO] 2020―Feb―21 Houston we have a problem: coronavirus! Philip Wiffen
 [1] 

60 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.006 sec